GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (TSE:4502) » Definitions » Cyclically Adjusted PB Ratio

Takeda Pharmaceutical Co (TSE:4502) Cyclically Adjusted PB Ratio : 1.24 (As of May. 14, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-05-14), Takeda Pharmaceutical Co's current share price is 円4205.00. Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円3,377.52. Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.24.

The historical rank and industry rank for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4502' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.03   Med: 1.39   Max: 2.42
Current: 1.21

During the past years, Takeda Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 2.42. The lowest was 1.03. And the median was 1.39.

TSE:4502's Cyclically Adjusted PB Ratio is ranked better than
65.81% of 664 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs TSE:4502: 1.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was 円4,635.575. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円3,377.52 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 1.40 1.19 1.37 1.24

Takeda Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.40 1.41 1.21 1.24

Competitive Comparison of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4205.00/3377.52
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Takeda Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4635.575/107.2000*107.2000
=4,635.575

Current CPI (Mar. 2024) = 107.2000.

Takeda Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 3,025.558 98.000 3,309.590
201409 3,120.720 98.500 3,396.357
201412 3,170.715 97.900 3,471.917
201503 2,719.263 97.900 2,977.579
201506 2,754.854 98.400 3,001.223
201509 2,696.079 98.500 2,934.210
201512 2,669.754 98.100 2,917.407
201603 2,487.039 97.900 2,723.295
201606 2,308.177 98.100 2,522.289
201609 2,321.385 98.000 2,539.311
201612 2,528.598 98.400 2,754.733
201703 2,425.924 98.100 2,650.959
201706 2,579.194 98.500 2,807.001
201709 2,669.927 98.800 2,896.925
201712 2,705.506 99.400 2,917.809
201803 2,556.510 99.200 2,762.680
201806 2,615.469 99.200 2,826.394
201809 2,775.239 99.900 2,978.034
201812 2,609.269 99.700 2,805.553
201903 3,332.938 99.700 3,583.661
201906 3,132.511 99.800 3,364.781
201909 3,123.553 100.100 3,345.104
201912 3,127.634 100.500 3,336.143
202003 3,032.208 100.300 3,240.805
202006 2,998.377 99.900 3,217.478
202009 2,982.296 99.900 3,200.222
202012 2,964.994 99.300 3,200.880
202103 3,308.922 99.900 3,550.715
202106 3,339.320 99.500 3,597.740
202109 3,384.940 100.100 3,625.031
202112 3,423.027 100.100 3,665.819
202203 3,643.872 101.100 3,863.730
202206 4,085.656 101.800 4,302.380
202209 4,318.329 103.100 4,490.057
202212 3,972.916 104.100 4,091.226
202303 4,087.488 104.400 4,197.114
202306 4,452.068 105.200 4,536.708
202309 4,506.595 106.200 4,549.030
202312 4,297.209 106.800 4,313.303
202403 4,635.575 107.200 4,635.575

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Takeda Pharmaceutical Co  (TSE:4502) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (TSE:4502) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (TSE:4502) Headlines

No Headlines